On May 15, 2020, the U.S. Food and Drug Administration (FDA) issued a warning letter to The Golden Road Kratom regarding violations related to the marketing and distribution of its kratom products. The letter cited concerns over misleading claims that suggest the products are safe and effective for medical use, which may mislead consumers about their potential risks. Additionally, the FDA expressed apprehensions about the lack of evidence supporting these claims and the potential for contamination or adulteration of the products. The warning highlighted the agency’s commitment to ensuring consumer safety and its intention to take further regulatory action if the company fails to comply with federal regulations regarding dietary supplements. The letter serves as a reminder of the ongoing scrutiny of kratom products and the importance of adhering to safety standards in the herbal supplement industry.

For further reading:

https://kri.org/wp-content/uploads/2024/10/The-Golden-Road-Kratom-Warning-Letter-05_15_2020.pdf